Gamma Knife System Market, Global Outlook and Forecast 2023-2028

Report ID: 1139261 | Published Date: Jan 2025 | No. of Page: 79 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story

This report contains market size and forecasts of Gamma Knife System in global, including the following market information:
Global Gamma Knife System Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Gamma Knife System Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Gamma Knife System companies in 2021 (%)
The global Gamma Knife System market was valued at 204 million in 2021 and is projected to reach US$ 251.1 million by 2028, at a CAGR of 3.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Head Gamma Knife System Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Gamma Knife System include GE Healthcare, Elekta AB, Varian Medical Systems, Mitsubishi Electric, Philips Healthcare, RaySearch, Nucletron, Nordion and BrainLab and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gamma Knife System manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gamma Knife System Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gamma Knife System Market Segment Percentages, by Type, 2021 (%)
Head Gamma Knife System
Body Gamma Knife System
Global Gamma Knife System Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gamma Knife System Market Segment Percentages, by Application, 2021 (%)
Brain Metastasis
Cancer
Arteriovenous Malformation (AVM)
Trigeminal Neuralgia
Others
Global Gamma Knife System Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Gamma Knife System Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gamma Knife System revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Gamma Knife System revenues share in global market, 2021 (%)
Key companies Gamma Knife System sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Gamma Knife System sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Elekta AB
Varian Medical Systems
Mitsubishi Electric
Philips Healthcare
RaySearch
Nucletron
Nordion
BrainLab
Huiheng Medical

Frequently Asked Questions
Gamma Knife System Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gamma Knife System Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gamma Knife System Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports